Gelesis Holdings, Inc.
Index- P/E- EPS (ttm)-1.33 Insider Own0.30% Shs Outstand72.77M Perf Week-21.04%
Market Cap28.05M Forward P/E- EPS next Y-0.27 Insider Trans33.23% Shs Float35.02M Perf Month-33.73%
Income- PEG- EPS next Q-0.26 Inst Own37.50% Short Float / Ratio1.46% / 1.54 Perf Quarter-27.10%
Sales26.03M P/S1.08 EPS this Y-396.40% Inst Trans5.25% Short Interest0.51M Perf Half Y-84.83%
Book/sh-0.05 P/B- EPS next Y78.90% ROA- Target Price- Perf Year-95.83%
Cash/sh0.19 P/C1.13 EPS next 5Y- ROE- 52W Range0.11 - 6.25 Perf YTD-41.51%
Dividend- P/FCF- EPS past 5Y- ROI32.00% 52W High-97.28% Beta-
Dividend %- Quick Ratio0.50 Sales past 5Y- Gross Margin- 52W Low54.41% ATR0.05
Employees101 Current Ratio0.70 Sales Q/Q116.10% Oper. Margin- RSI (14)39.13 Volatility54.55% 23.36%
OptionableNo Debt/Eq- EPS Q/Q73.00% Profit Margin- Rel Volume6.62 Prev Close0.21
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume332.95K Price0.17
Recom3.00 SMA20-29.57% SMA50-43.11% SMA200-81.06% Volume324,939 Change-19.08%
Jan-05-23 07:00AM
Nov-21-22 07:00AM
Nov-18-22 06:00PM
Nov-14-22 07:00AM
Nov-07-22 07:00AM
06:00PM Loading…
Nov-04-22 06:00PM
Nov-02-22 07:30AM
Nov-01-22 05:24PM
Sep-08-22 07:00AM
Aug-25-22 07:00AM
Aug-17-22 03:19PM
Aug-16-22 11:59AM
Aug-15-22 09:00AM
04:05PM Loading…
Aug-04-22 04:05PM
Jun-21-22 06:30AM
Jun-05-22 08:00AM
Jun-04-22 11:00AM
May-18-22 04:05PM
May-12-22 04:00PM
May-09-22 06:00AM
May-04-22 06:31AM
Apr-29-22 06:00AM
Mar-24-22 04:00PM
Mar-17-22 06:30AM
Mar-16-22 06:30AM
Jan-31-22 06:45AM
Jan-19-22 06:24AM
Gelesis Holdings Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. The company also provides PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, it offers a product for obesity and overweight and a pipeline with potential therapies for non-alcoholic fatty liver disease/non-alcoholic steatohepatitis, type 2 diabetes, and GS500 for Functional Constipation. Gelesis Holdings Inc. was incorporated in 2006 and is headquartered in Boston, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KUCHERLAPATI RAJU SDirectorNov 21Buy0.4592,00041,400190,264Nov 22 06:20 PM
KUCHERLAPATI RAJU SDirectorNov 18Buy0.398,0003,12098,264Nov 22 06:20 PM
KUCHERLAPATI RAJU SDirectorJun 15Buy1.9524,62547,94790,264Jun 17 10:46 AM